MECP2 and Rett syndrome: Gail Mandel led a second study that showed that intravenous AAV9/MeCP2e1 vector reduced motor defects in Bird Mecp2–/+ deficient female mice, which thus had greater relevance to Rett syndrome as 95% of Rett patients are female (Garg et al., 2013).